Preventing a heart attack is certainly the best strategy to avoid fatal events but also serious consequences and disabilities.
If you think therenfarto and the image is obviously the most “nefarious” one. But who remains alive can manifest very important health consequences. Therefore, preventing heart attack relapses is a must. And we can make it through numerous synergistic projects. But today we have another weaponwhich probably will revolutionize the sector of cardiovascular diseases.
To date, mortality from cardiovascular diseases is very high, despite the fact that they are known and therefore better “manageable” pathologies. In the worldalmost die every year 18 million people. In Italiawe are about a 130 thousand cases per year. But that is not all.
As can be seen from a report published on the ISS websitevery often those who survive the acute form of the event become chronically ill. A high percentage goes towards other heart attacks in the next 12 months. They then trigger premature aging and therefore related disorders. Like them cognitiveas well as disability physical of various kinds and cases of permanent disability. Heart attack is a very costly social disease.
It becomes even more basic then disclose useful information. Because cardiocerebrovascular diseases are fought effectively by adopting healthier lifestyles and balanced. Together with these notions and the already existing drugs, today we have another weapon to decrease drastically il number of events and theirs consequences. Here’s what it is.
Tests on the use of a protein to prevent heart attack are underway
It is a very recent one promoted study fromHarvard Medical School di Boston. The purpose is to start testing on at least 20 thousand subjects a new treatment. This is theuse of a proteinthe “apolipoprotein apoA-I“.
It is called “sponge protein” because it seems to work just like that. Quite simply, would be able to clear the arteries of atherosclerotic plaques. And therefore “save” from the resulting heart attacks.
Obviously we “tell” it simpler but scientists worked hard to come up with this therapy. That would be to inject this protein intravenously. In contact with the platesfor reasons understandable only to those in the branch, the apolipoprotein would begin to attract them. By managing to detach them from the arteries. As we know, therapy today consists in avoiding the growth of (even further) plaques. In this way the “cleaning” it would be really deep.
Trials and the purpose of experimentation
Le people subjected to this new therapyas we said, will be at least 20 thousand and will be selected worldwide. Therefore also in Italy. In our country the IRCCS MultiMedica of Sesto San Giovanni will be involved.
Give one’interview published on ANSA we understand the purpose of the tests. According to the statements of Roberto Pedretti, the director of the Cardiovascular Department of IRCCS, one of the goals is to prevent ch after the first event other events occur. Especially during the next 3 months, the most critical period for anyone who has had a heart attack.
It is about a completely innovative approach compared to existing drug therapies. And the good news is that the first effects seem to be very encouraging.